News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RheoGene, Inc. Grants Ichor Medical Systems, Inc. A Commercial License To Develop A Regulated Gene Therapy For Multiple Sclerosis Using The RheoSwitch® Therapeutic System


2/9/2006 2:09:51 PM

RheoGene, Inc., announced today that it has granted a commercial license to Ichor Medical Systems for use of its RheoSwitch® Therapeutic System (RTS) in combination with Ichor Medical Systems’ proprietary TriGrid™ Delivery System electroporation technology to develop a gene therapy product for multiple sclerosis. The agreement also grants Ichor an option to use RTS in two additional indications. Ichor has also granted an option for RheoGene to license Ichor’s TriGrid™ Delivery System to develop proprietary therapeutics.

Read at PRWEB


comments powered by Disqus
PRWEB
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES